-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2021.jsp
January 01, 2021 - data elements that are not uniformly available across
States, such as AHA hospital identifiers, secondary … elements that were not available
uniformly across the States, such as hospital identifiers, secondary … information
ICD-10-CM diagnoses
I10_DX1 — I10_DX40
ICD-10-CM diagnoses, principal and secondary … the record
ICD-10-PCS procedures
I10_PR1 — I10_PR25
ICD-10-PCS procedures, principal and secondary … from admission to principal
procedure
PRDAY2 —PRDAY25
Number of days from admission to secondary
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2020.jsp
January 01, 2020 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information
ICD-10-CM diagnoses
I10_DX1 - I10_DX40
ICD-10-CM diagnoses, principal and secondary … the record
ICD-10-PCS procedures
I10_PR1 - I10_PR25
ICD-10-PCS procedures, principal and secondary … days from admission to principal procedure
PRDAY2 - PRDAY25
Number of days from admission to secondary
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2016.jsp
January 01, 2016 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information
ICD-10-CM diagnoses
I10_DX1 - I10_DX30
ICD-10-CM diagnoses, principal and secondary … ICD-10-PCS procedures
I10_PR1 - I10_PR15
ICD-10-PCS procedures, principal and secondary
I10 … days from admission to principal procedure
PRDAY2 - PRDAY15
Number of days from admission to secondary
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2019.jsp
January 01, 2019 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information
ICD-10-CM diagnoses
I10_DX1 - I10_DX40
ICD-10-CM diagnoses, principal and secondary … the record
ICD-10-PCS procedures
I10_PR1 - I10_PR25
ICD-10-PCS procedures, principal and secondary … days from admission to principal procedure
PRDAY2 - PRDAY25
Number of days from admission to secondary
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2018.jsp
January 01, 2018 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information
ICD-10-CM diagnoses
I10_DX1 - I10_DX40
ICD-10-CM diagnoses, principal and secondary … the record
ICD-10-PCS procedures
I10_PR1 - I10_PR25
ICD-10-PCS procedures, principal and secondary … days from admission to principal procedure
PRDAY2 - PRDAY25
Number of days from admission to secondary
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
July 15, 2007 - dyslipidemias (polygenic, risk factor associated, or multi-factorial), while a minority will have monogenic or secondary … loss for overweight children, and identification and treatment of diabetes mellitus or other causes of secondary … undiagnosed monogenic dyslipidemias, such as familial hypercholesterolemia; those with undiagnosed secondary … adolescents identified by screening include those with undiagnosed monogenic dyslipidemia, undiagnosed secondary … Children and adolescents with previously known monogenic or secondary dyslipidemia would be specifically
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core_Weighted.PDF
January 01, 2012 - Frequency Distribution for DRG24
DRG24 Frequency
Percent
of Total
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 133,005 0.36%
464: SIGNS & SYMPTOMS W/O CC 33,830 0.09%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 740 0.00%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 8,715 0.02%
467 … 0.11%
40: Multiple myeloma 18,435 0.05%
41: Cancer; other and unspecified primary 7,400 0.02%
42: Secondary … Distribution for DXCCS1
DXCCS1 Frequency
Percent
of Total
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
January 01, 2007 - NEOPL W OTHER O.R.PROC 6481 0.02
409: RADIOTHERAPY 4259 0.01
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 109239 0.28
464: SIGNS & SYMPTOMS W/O CC 35309 0.09
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1836 0.00
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 20076 0.05
467 … 43544 0.11
40: Multiple myeloma 18228 0.05
41: Cancer; other and unspecified primary 8458 0.02
42: Secondary … Distribution for DXCCS1
DXCCS1 Frequency
Percent
of
Total
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core.PDF
January 01, 2012 - NEOPL W OTHER O.R.PROC 307 0.01%
409: RADIOTHERAPY 102 0.00%
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 2,125 0.07%
464: SIGNS & SYMPTOMS W/O CC 2,384 0.07%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS <= 10 *.**%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY
DIAGNOSIS
853 0.03%
467 … 0.16%
40: Multiple myeloma <= 10 *.**%
41: Cancer; other and unspecified primary 1,422 0.04%
42: Secondary … disease)
2,746 0.09%
98: Essential hypertension 650 0.02%
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core_Weighted.PDF
January 01, 2012 - NEOPL W OTHER O.R.PROC 438 0.01%
409: RADIOTHERAPY 145 0.00%
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 3,012 0.05%
464: SIGNS & SYMPTOMS W/O CC 3,360 0.05%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS <= 50 *.**%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY
DIAGNOSIS
1,199 0.02% … 0.11%
40: Multiple myeloma <= 50 *.**%
41: Cancer; other and unspecified primary 2,027 0.03%
42: Secondary … disease)
3,867 0.06%
98: Essential hypertension 929 0.01%
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core_Weighted.PDF
January 01, 2006 - NEOPL W OTHER O.R.PROC 5676 0.01
409: RADIOTHERAPY 4779 0.01
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … W CC 71365 0.18
464: SIGNS & SYMPTOMS W/O CC 23109 0.06
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 2454 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 23579 0.06
467 … Leukemias 39032 0.10
40: Multiple myeloma 16363 0.04
41: Cancer, other Unspecified primary 7607 0.02
42: Secondary … diseases) 89793 0.23
98: Essential hypertension 81898 0.21
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q1Q3_IP_MaskedStats.PDF
October 01, 2014 - DIAGNOSIS W MCC 56 0.00
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 165 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 14 0.00
849: RADIOTHERAPY 18 … DIAGNOSIS W MCC 56 0.00
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 165 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 14 0.00
849: RADIOTHERAPY 18 … 3,030 0.10
40: Multiple myeloma 1,280 0.04
41: Cancer; other and unspecified primary 390 0.01
42: Secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
September 23, 2010 - only 210
enrolled: groups were
unbalanced on mental
status
Primary:
reoperation
by 1 year;
secondary … 1 year)
used 5 point
scale
No significant differences in
reoperation at 1 year or EQ-5D,
any secondary … Secondary:
mortality,
pain, hip
function and
mobility
No significant
differences mortality
at … Secondary:
perioperative
factors
Decreased trend in
early mortality in
PCCp group
(p=0.51).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
May 01, 2025 - Comparator Any No comparator
Outcome
Primary outcome: Any patient safety
event
Secondary … The two new studies did not meet eligibility criteria for
this report because one reported only secondary … Author,
Year
Study
Design
Setting HRO
Framework
HRO Activities* Primary Outcome
Measures
Secondary … Primary study results and quality
Author,
Year
Primary Outcomes Secondary Outcomes Quality
Sculli
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - Evidence identified through the systematic evidence review for diagnosis was
also used as a secondary
-
www.ahrq.gov/patient-safety/settings/hospital/vtguide/appb2.html
January 01, 2020 - The nephrotic syndrome is thought to be secondary to primary membranous nephropathy.
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm3.html
October 01, 2014 - claims data from the Community Care of North Carolina (CCNC) sites demonstrated that the primary and secondary
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/module-10-slides.pdf
February 24, 2022 - Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical
-
www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/appb2.html
January 01, 2020 - The nephrotic syndrome is thought to be secondary to primary membranous nephropathy.
-
digital.ahrq.gov/ahrq-funded-projects/project-echo-extension-community-healthcare-outcomes
January 01, 2023 - A secondary goal was to provide rural healthcare practitioners with a level of interaction and support